Valentina TOMEI 

PhD Program years: 2008- 2011

1. Imatinib treatment inhibits IL-6, IL-8, NF-KB and AP-1 production and modulate intracellular calcium in CML patients.
   Ciarcia R, Vitiello MT, Galdiero M, Pacilio C, Iovane V, d'Angelo D, Pagnini D, Caparrotti G, Conti D, Tomei V, Florio S, Giordano A.
   J Cell Physiol. 2011 Sep 21
   
   
2. New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization.
   Indovina P, Giorgi F, Rizzo V, Khadang B, Schenone S, Di Marzo D, Forte IM, Tomei V, Mattioli E, D'Urso V, Grilli B, Botta M, Giordano A, Pentimalli F.
   Oncogene. 2011 Jul 25
   
   
3. Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats.
   Aloisi AM, Ceccarelli I, Fiorenzani P, Maddalena M, Rossi A, Tomei V, Sorda G, Danielli B, Rovini M, Cappelli A, Anzini M, Giordano A.
   Mol Pain. 2010 Oct 26;6:69.
   
   
4. Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma.
   Indovina P, Acquaviva A, De Falco G, Rizzo V, Onnis A, Luzzi A, Giorgi F, Hadjistilianou T, Toti P, Tomei V, Pentimalli F, Carugi A, Giordano A.
   J Cell Physiol. 2010 Apr;223(1):143-50.
   

1. Conference abstract title
   Conference title, Date
   Location
   

---